Patent · US Active

Therapeutic agents

US10865231B2 · kind B2 · utility

2Cited by
6References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2020
Grant dateDec 15, 2020
Priority date
Expiry dateMay 18, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunoresponsive cell, such as a T-cell expressing This arrangement is referred to as parallel chimeric activating receptors (pCAR). Cells of this type are useful in therapy, and kits and methods for using them as well as methods for preparing them are described and claimed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.